Kulumani Sivarajan
Hematology & Oncology · Joliet, ILNPI 1952396582
Payments from drug & device makers
Across 101 payments — averaging $192.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$9K
- GSK$2K
- Beigene, Ltd.$2K
- Bristol Myers Squibb$2K
- Karyopharm Therapeutics Inc.$2K
- Astrazeneca UK Limited$1K
- plus $2K from 35 others
What the payments were for
- Consulting fees$17,50390%
- Speaking & faculty fees$2501%
- Food & beverage$1,6248%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,430 in reported general payments places this provider in the 55th percentile of 580 hematology & oncology providers in Illinois.
Other hematology & oncology in Joliet
- Nafisa BurhaniJoliet$3.4M
- Richard SchilskyBurr Ridge$87.1M
- Edwin PosadasBurr Ridge$70.9M
- Oana DanciuChicago$23.2M
- Shuo MaChicago$20.5M
- Olwen HahnChicago$11.9M
- Christine BestvinaChicago$11.3M
- Russell SzmulewitzChicago$9.8M
- Randy SweisChicago$9.4M
- Hedy KindlerChicago$8.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.